Jw Life Science Corp (234080) — Financial Flexibility Index
Jw Life Science Corp (234080) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of ₩9.35 Billion (operating CF ₩5.08 Billion minus capex ₩4.27 Billion) represents 0% of total liabilities (₩97.63 Billion). Check Jw Life Science Corp PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jw Life Science Corp Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Jw Life Science Corp across 11 annual periods. See 234080 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jw Life Science Corp (2015–2025)
Year-by-year free cash flow to debt coverage for Jw Life Science Corp. For the full company profile including market capitalisation, see 234080 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | ₩53.97 Billion | ₩40.54 Billion | ₩97.63 Billion | ▲ +13.2% |
| 2024 | 0.49x | ₩61.00 Billion | ₩50.69 Billion | ₩124.88 Billion | ▲ +2.8% |
| 2023 | 0.48x | ₩45.84 Billion | ₩37.57 Billion | ₩96.44 Billion | ▲ +138.7% |
| 2022 | 0.20x | ₩22.42 Billion | ₩14.13 Billion | ₩112.61 Billion | ▼ -64.4% |
| 2021 | 0.56x | ₩49.14 Billion | ₩30.17 Billion | ₩87.97 Billion | ▼ -23.4% |
| 2020 | 0.73x | ₩62.69 Billion | ₩46.75 Billion | ₩85.98 Billion | ▲ +77.5% |
| 2019 | 0.41x | ₩32.37 Billion | ₩24.28 Billion | ₩78.79 Billion | ▼ -18.5% |
| 2018 | 0.50x | ₩46.17 Billion | ₩36.13 Billion | ₩91.60 Billion | ▲ +57.7% |
| 2017 | 0.32x | ₩30.82 Billion | ₩22.05 Billion | ₩96.43 Billion | ▲ +10.6% |
| 2016 | 0.29x | ₩29.45 Billion | ₩16.08 Billion | ₩101.94 Billion | ▼ -42.8% |
| 2015 | 0.51x | ₩49.03 Billion | ₩25.90 Billion | ₩97.05 Billion | — |